276 related articles for article (PubMed ID: 28383433)
41. TTK is a favorable prognostic biomarker for triple-negative breast cancer survival.
Xu Q; Xu Y; Pan B; Wu L; Ren X; Zhou Y; Mao F; Lin Y; Guan J; Shen S; Zhang X; Wang C; Zhong Y; Zhou L; Liang Z; Zhao H; Sun Q
Oncotarget; 2016 Dec; 7(49):81815-81829. PubMed ID: 27833085
[TBL] [Abstract][Full Text] [Related]
42. CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.
Pedersen MH; Hood BL; Ehmsen S; Beck HC; Conrads TP; Bak M; Ditzel HJ; Leth-Larsen R
Int J Cancer; 2019 Feb; 144(3):631-640. PubMed ID: 30110125
[TBL] [Abstract][Full Text] [Related]
43. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
Zhou C; Sun B
Oral Oncol; 2014 Dec; 50(12):1144-8. PubMed ID: 25264224
[TBL] [Abstract][Full Text] [Related]
44. Androgen Receptor and ALDH1 Expression Among Internationally Diverse Patient Populations.
Jiagge E; Jibril AS; Davis M; Murga-Zamalloa C; Kleer CG; Gyan K; Divine G; Hoenerhoff M; Bensenhave J; Awuah B; Oppong J; Adjei E; Salem B; Toy K; Merajver S; Wicha M; Newman L
J Glob Oncol; 2018 Oct; 4():1-8. PubMed ID: 30307804
[TBL] [Abstract][Full Text] [Related]
45. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.
Deng S; Yang X; Lassus H; Liang S; Kaur S; Ye Q; Li C; Wang LP; Roby KF; Orsulic S; Connolly DC; Zhang Y; Montone K; Bützow R; Coukos G; Zhang L
PLoS One; 2010 Apr; 5(4):e10277. PubMed ID: 20422001
[TBL] [Abstract][Full Text] [Related]
46. GLO 1 and PKCλ Regulate ALDH1-positive Breast Cancer Stem Cell Survival.
Motomura H; Tamori S; Yatani MA; Namiki A; Onaga C; Ozaki A; Takasawa R; Mano Y; Sato T; Hara Y; Sato K; Xiong Y; Harada Y; Hanawa T; Tanuma SI; Sasaki K; Ohno S; Akimoto K
Anticancer Res; 2021 Dec; 41(12):5959-5971. PubMed ID: 34848450
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Rao RS; Raju K L; Augustine D; Patil S
Cancer Control; 2020; 27(1):1073274820904959. PubMed ID: 32951453
[TBL] [Abstract][Full Text] [Related]
48. Lymphocyte-predominant triple-negative breast carcinomas in premenopausal patients: Lower expression of basal immunohistochemical markers.
Masili-Oku SM; Almeida BGL; Bacchi CE; Filassi JR; Baracat EC; Carvalho FM
Breast; 2017 Feb; 31():34-39. PubMed ID: 27810697
[TBL] [Abstract][Full Text] [Related]
49. Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma.
Nakahata K; Uehara S; Nishikawa S; Kawatsu M; Zenitani M; Oue T; Okuyama H
PLoS One; 2015; 10(4):e0125454. PubMed ID: 25915760
[TBL] [Abstract][Full Text] [Related]
50. The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population.
Gyan E; Green A; Ahenkorah-Fondjo L; Jackson A; Toss MS; Akakpo PK; Derkyi-Kwarteng L; Rahman GA; Owiredu W
Ann Diagn Pathol; 2021 Apr; 51():151696. PubMed ID: 33460998
[TBL] [Abstract][Full Text] [Related]
51. An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer.
Lee HE; Kim JH; Kim YJ; Choi SY; Kim SW; Kang E; Chung IY; Kim IA; Kim EJ; Choi Y; Ryu HS; Park SY
Br J Cancer; 2011 May; 104(11):1730-8. PubMed ID: 21559013
[TBL] [Abstract][Full Text] [Related]
52. Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study.
Abourbih S; Sircar K; Tanguay S; Kassouf W; Aprikian A; Mansure J; Brimo F
World J Surg Oncol; 2013 Nov; 11():298. PubMed ID: 24266898
[TBL] [Abstract][Full Text] [Related]
53. In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.
Neumeister V; Agarwal S; Bordeaux J; Camp RL; Rimm DL
Am J Pathol; 2010 May; 176(5):2131-8. PubMed ID: 20228222
[TBL] [Abstract][Full Text] [Related]
54. Prognostic Impact of ALDH1 Expression in Transitional Cell Carcinoma of the Renal Pelvis.
Liu J; Jin J; Yang Y; Han W; Yu W; Shen C; Zhang N; Du P; Zhao Q; Wang S; Tang X
Anticancer Res; 2015 Sep; 35(9):4829-36. PubMed ID: 26254374
[TBL] [Abstract][Full Text] [Related]
55. Decreased expression of autophagy protein LC3 and stemness (CD44+/CD24-/low) indicate poor prognosis in triple-negative breast cancer.
Chang SJ; Ou-Yang F; Tu HP; Lin CH; Huang SH; Kostoro J; Hou MF; Chai CY; Kwan AL
Hum Pathol; 2016 Feb; 48():48-55. PubMed ID: 26772398
[TBL] [Abstract][Full Text] [Related]
56. A prospective study of association of cancer stem cell marker aldehyde dehydrogenase 1 with clinicopathological profile in lung carcinoma patients.
Tiwari N; Srivastava AN; Tandon N; Lal N; Yadav S; Kant S; Jain M
Indian J Pathol Microbiol; 2018; 61(4):489-494. PubMed ID: 30303135
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma.
Yu L; Zhu B; Wu S; Zhou L; Song W; Gong X; Wang D
Diagn Pathol; 2017 Mar; 12(1):23. PubMed ID: 28253891
[TBL] [Abstract][Full Text] [Related]
58. Aldehyde Dehydrogenase-1 Expression Predicts Unfavorable Outcomes in Patients with Esophageal Squamous Cell Carcinoma.
Ji Y; Li X; Li Y; Zhong Y; Cao J; Xu R; Wang J; Zhou F; Li X; Yu D; Wen JG; Goscinski MA; Zhang M; Nesland JM; Suo Z
Anticancer Res; 2016 Jan; 36(1):343-9. PubMed ID: 26722063
[TBL] [Abstract][Full Text] [Related]
59. Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.
Bednarz-Knoll N; Nastały P; Żaczek A; Stoupiec MG; Riethdorf S; Wikman H; Müller V; Skokowski J; Szade J; Sejda A; Wełnicka-Jaśkiewicz M; Pantel K
Oncotarget; 2015 Sep; 6(29):26789-803. PubMed ID: 26305673
[TBL] [Abstract][Full Text] [Related]
60. Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications.
Rahadiani N; Ikeda J; Mamat S; Matsuzaki S; Ueda Y; Umehara R; Tian T; Wang Y; Enomoto T; Kimura T; Aozasa K; Morii E
Cancer Sci; 2011 Apr; 102(4):903-8. PubMed ID: 21231983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
